Innovation/Impact: This study is novel because it is one of the first investigations to incorporate the interplay effect between tumor motion, gantry rotation and MLC sequencing into dose calculation for volumetric arc therapy (RapidArc) of lung cancers treated with SBRT. Other studies, incorporating interplay effects, have been based on a convolution of static planned dose with the motion probability density function (1) or on phantom measurements (2, 3). However, none have investigated the interplay effect in the volumetric arc therapy setting using realistic clinical data. The results of this work will be beneficial to the clinical team in deciding whether or not to utilize RapidArc to treatment of "mobile" tumors.
Methods: Dividing the arcs into sub-arcs and associating them with respiration phases: The figure in left shows how the arcs were divided into sub-arcs and associated with different respiratory phases. The gantry rotation angle for each sub-arc was determined by the gantry rotation speed and time interval of each phase.
